| Overview |
| bsm-70625m-100ul |
| Prion Protein Antibody |
| WB, IHC |
| The antibody detects endogenous prion protein in human PC3 and A431 cell lines. In addition, the antibody strongly detects human recombinant Prion protein, and weakly detects bovine recombinant Prion protein. This sequence is conserved in feline and hamster, but is less conserved in rat and mouse Prion protein. |
| Human |
| Specifications |
| Unconjugated |
| Mouse |
| Clone 3F4 was generated from a synthetic peptide taken from amino acids in the central region of human prion protein. |
| Monoclonal |
| 3F4 |
| IgG2a |
| Purified by Protein A. |
| PBS + 1 mg/ml BSA, 0.05% NaN3 and 50% glycerol |
| Storage at -20°C is recommended, as aliquots may be taken without freeze/thawing due to presence of 50% glycerol. Stable for at least 1 year at -20°C. |
| Target |
| P04156 |
| PrP, PrPsc, PrPc |
| Prion related neurodegenerative diseases, called transmissible spongiform encephalopathies, are observed in many animal species. These diseases involve conversion of normal cellular prion protein (PrPc) into a form that is insoluble and resistant to proteases (PrPSc). The protease resistant form can polymerize into fibrils which accumulate in infected tissues and cause cell death and tissue damage. PrPs have an N-terminal signal sequence and a C-terminal linkage to glycosylphosphatidylinositol anchor. The mature protein is a glycosylated protein that associates with cell membranes. Phosphorylation of PrPC at Ser-43 by Cdk5 promotes proteinase K resistance, prion aggregation, and fibril formation in vitro. In addition, Ser-43 phosphorylation is upregulated in scrapie-infected mouse brain relative to controls. Thus, phosphorylation of Ser-43 may be an important mechanism leading conversion of PrPc to PrPSc and the onset of disease. |
| Application Dilution |
| WB |
1:300-5000 |
| IHC |
|
Powered by Bioz